Canine Da2Ppv (Orig S-P Us) Lv

363 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

363

Total Reports

Deaths Reported

1820.0%

Death Rate

Active Ingredients

Canine Da2Ppv (Orig S-P Us) Lv

Administration Routes

SubcutaneousUnknownIntramuscularSubconjunctival

Species Affected

Dog 363

Most Affected Breeds

Crossbred Canine/dog 92

Retriever - Labrador 24

Chihuahua 20

Shih Tzu 18

Terrier - Yorkshire 16

Shepherd Dog - German 15

Retriever - Golden 13

Spitz - German Pomeranian 10

Pit Bull 9

Boxer (German Boxer) 8

Most Reported Reactions

Vomiting 113

Lethargy (see also Central nervous system depression in 'Neurological') 75

Diarrhoea 66

Emesis (multiple) 55

Death 39

Anorexia 28

Seizure NOS 25

Not eating 24

Death by euthanasia 24

Lack of efficacy (virus) - parvovirus (including feline panleukopenia) 22

Other abnormal test result NOS 20

Fever 19

Outcome Breakdown

Recovered/Normal

151 (40.6%)

Ongoing

112 (30.1%)

Died

42 (11.3%)

Outcome Unknown

35 (9.4%)

Euthanized

25 (6.7%)

Recovered with Sequela

7 (1.9%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.